Wikisage, the free encyclopedia of the second generation, is digital heritage
Ethosuximide: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
mNo edit summary |
||
Line 3: | Line 3: | ||
==ATC== | ==ATC== | ||
https://www.whocc.no/atc_ddd_index/?code=N03AD01 | https://www.whocc.no/atc_ddd_index/?code=N03AD01 | ||
{{wikidata|Q421567}} | |||
[https://bmjopen.bmj.com/content/6/12/e013530 Assessment of the effectiveness and safety of Ethosuximide in the Treatment of non-Diabetic Peripheral Neuropathic Pain: EDONOT—protocol of a randomised, parallel, controlled, double-blinded and multicentre clinical trial] | [https://bmjopen.bmj.com/content/6/12/e013530 Assessment of the effectiveness and safety of Ethosuximide in the Treatment of non-Diabetic Peripheral Neuropathic Pain: EDONOT—protocol of a randomised, parallel, controlled, double-blinded and multicentre clinical trial] | ||
<references/> | <references/> |
Revision as of 01:16, 11 August 2018
non applicable in focal onset impaired awareness seizure[1]
ATC
https://www.whocc.no/atc_ddd_index/?code=N03AD01